SCHEMBL25808865

SCHEMBL25808865

C=C/C=C\C(=C/C=C)S(=O)(=O)NC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21338942 0.79 — —
SCHEMBL21338941 0.79 — —
SCHEMBL21016677 0.78 — —
SCHEMBL19336688 0.74 — —
SCHEMBL23046590 0.72 — —
SCHEMBL25809038 0.72 — —
SCHEMBL22844063 0.72 CA2 (0.37) —
SCHEMBL18715569 0.71 — —
SCHEMBL18861975 0.71 — —
SCHEMBL21768487 0.69 KEAP1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114366-A2 SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2023-06-22 — — WO disclosed
Send feedback